Anika Therapeutics
Yahoo Finance • 2 months ago
Politan Provides Update on Why Masimo Shareholders Should Support Urgently Needed Board Change at Company’s 2024 AGM
Sends Letter to Shareholders Reiterating Why Voting for Both Politan’s "Highly Credible and Capable" Nominees Is Essential in Order to Safeguard Shareholder Value and Realize Masimo’s Potential Highlights Key Facts Brought to Light During... Full story
Yahoo Finance • 11 months ago
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD, Mass., Nov. 28, 2023 (GLOBE NEWSWIRE) -- A... Full story
Yahoo Finance • 12 months ago
Anika to Participate in Upcoming Investor Conferences
BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Of... Full story
Yahoo Finance • last year
Q3 2023 Anika Therapeutics Inc Earnings Call
Participants Cheryl Renee Blanchard; President, CEO & Director; Anika Therapeutics, Inc. Mark Namaroff; Executive Director of IR & Corporate Communications; Anika Therapeutics, Inc. Michael L. Levitz; Executive VP, CFO & Treasurer; Anik... Full story
Yahoo Finance • last year
Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance
Anika Therapeutics Inc (NASDAQ:ANIK) reported a 3% increase in revenue for Q3 2023, with total revenue reaching $41.5 million. Joint Preservation and Restoration revenue grew by 14%, while OA Pain Management revenue saw a 2% increase. The... Full story
Yahoo Finance • last year
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively RevoMotion™ Reverse Shoulder Arthroplasty System Fully L... Full story
Yahoo Finance • last year
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its third quarter 2023 fina... Full story
Yahoo Finance • last year
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in the $1 billion1 U.S. reverse shoulder market RevoMotion adds to a grow... Full story
Yahoo Finance • last year
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 5, 2023, Anika granted restricted stock... Full story
Yahoo Finance • last year
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Small Cap V... Full story
Yahoo Finance • last year
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure, resulting in higher strength and greater regenerative capacity compared to first generation b... Full story
Yahoo Finance • last year
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide time-saving regenerative solutions for Sports Medicine surgeons Clinical outcomes o... Full story
Yahoo Finance • last year
Anika Reports First Quarter 2023 Financial Results
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2023.... Full story
Yahoo Finance • 2 years ago
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2023 fin... Full story
Yahoo Finance • 2 years ago
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
Anika Therapeutics Inc. BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in... Full story
Yahoo Finance • 2 years ago
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika reaches agreement to distribute the Marrow Cellution™ Bone Marrow Aspiration Needle in the U.S. and commences l... Full story
Yahoo Finance • 2 years ago
Anika Files Preliminary Proxy Statement
BEDFORD, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today announced that it has filed its prelimina... Full story
Yahoo Finance • 2 years ago
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
Recently Commenced Full Market Release of X-Twist™ Fixation System, a Cornerstone Product in Anika’s Sports Medicine Portfolio RevoMotion™ Reverse Shoulder Arthroplasty System Now in Limited Market Release in U.S. OVOMotion® with Inlay G... Full story
Yahoo Finance • 2 years ago
Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results
Delivered Fourth Quarter Revenue Growth of 11% and Full Year 2022 Revenue Growth of 6% Completed First Surgeries and Initiated Limited Market Release of New RevoMotion™ Reverse Shoulder Arthroplasty System Commenced Full Market Release o... Full story
Yahoo Finance • 2 years ago
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
BEDFORD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity M... Full story
